Andlauer Healthcare Group (TSE:AND – Get Free Report) had its price target dropped by TD Securities from C$54.00 to C$53.00 in a report issued on Friday,BayStreet.CA reports. The firm presently has a “buy” rating on the stock. TD Securities’ target price suggests a potential upside of 30.29% from the company’s previous close.
Other equities research analysts also recently issued reports about the stock. Stifel Nicolaus upped their target price on shares of Andlauer Healthcare Group from C$50.00 to C$52.00 in a report on Monday. National Bankshares boosted their target price on shares of Andlauer Healthcare Group from C$45.00 to C$49.00 and gave the company a “sector perform” rating in a research note on Tuesday, February 11th. Finally, Scotiabank upped their price objective on shares of Andlauer Healthcare Group from C$43.00 to C$44.00 in a research report on Thursday, November 7th. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of C$48.71.
View Our Latest Analysis on AND
Andlauer Healthcare Group Stock Down 3.7 %
Andlauer Healthcare Group Company Profile
Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.
Recommended Stories
- Five stocks we like better than Andlauer Healthcare Group
- Differences Between Momentum Investing and Long Term Investing
- Analysts Lift Archer Aviation Stock Despite Earnings Miss
- Best Stocks Under $10.00
- 5 Best Gold ETFs for March to Curb Recession Fears
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
Receive News & Ratings for Andlauer Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andlauer Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.